Biological Factors for Age-Related Macular Degeneration
Principal Investigator
Johanna Seddon, MD
University of Massachusetts School of Medicine
Worcester, MA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$42,362
Active Dates
April 01, 2002 - March 31, 2003
Grant ID
M2002048
Summary
The objective of this study is to test whether known biological markers of inflammation are correlated with the progression of age-related macular degeneration (AMD). Dr. Seddon hypothesizes that AMD is mediated, at least in part, by the same factors shown to be related to other age-related diseases, like atherosclerosis. These factors include chronic inflammation, oxidative processes, and nutritional factors. Dr. Seddon is examining the levels of three inflammatory markers in serum: C-reactive protein, interleukin-6, and tumor necrosis factor. She will measure the level of these factors in the serum of 474 patients from the Age-Related Eye Disease Study (AREDS), sponsored by the National Eye Institute, and correlate them to the progression of AMD. Identifying circulating risk factors for AMD may constitute a useful means for screening for AMD in a clinical setting. It is also hoped that the identification of modifiable risk factors can lead to improved therapies and possible prevention of this disease.
Grantee institution at the time of this grant: Massachusetts Eye and Ear Infirmary
Related Grants
Macular Degeneration Research
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Current Organization
University of Alberta
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Brittany Carr, PhD
Current Organization
University of Alberta
Macular Degeneration Research
Storing Fat in the Eye: A Pathway for Tackling AMD
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
John Han, PhD
Current Organization
University of Michigan Medical Center
Storing Fat in the Eye: A Pathway for Tackling AMD
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
John Han, PhD
Current Organization
University of Michigan Medical Center
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital